Forest launches COPD product Tudorza in USA
12 December 2012
Almirall looks to robust 2012 despite higher losses
28 February 2012
Stock Commentary - New York week to Jan 12, 2009
19 January 2009
Stock Commentary - New York week to March 3, 2008
10 March 2008
Stock Commentary - New York week to Feb 11, 2008
18 February 2008
Mylan
15 October 2007
Dey's Perforomist effective against COPD
28 May 2007
US FDA approves Dey's Perforomist
21 May 2007
Showing 1-9 of 9 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
